Parallax Volatility Advisers, L.P. Eye Point Pharmaceuticals, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $49.8 Billion
- Q4 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 91,400 shares of EYPT stock, worth $553,884. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,400Holding current value
$553,884% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding EYPT
# of Institutions
155Shares Held
72.2MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$50.4 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$41.1 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$34.8 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$25.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$23 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $206M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...